EODData

OTCBB, SMDPY: Sumitomo Pharma CO U/Adr

10 Mar 2026
LAST:

12.14

CHANGE:
 0.96
OPEN:
13.25
HIGH:
13.25
ASK:
0.00
VOLUME:
1.8K
CHG(%):
7.33
PREV:
13.10
LOW:
12.14
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
10 Mar 2613.2513.2512.1412.141.8K
09 Mar 2613.1014.4812.0013.101.5K
06 Mar 2612.4412.4412.4412.441.3K
03 Mar 2612.0012.0012.0012.001.0K
02 Mar 2615.0015.0015.0015.001.0K
24 Feb 2615.3415.3415.3415.34100
20 Feb 2618.2018.2018.1818.20300

PROFILE

Name:Sumitomo Pharma CO U/Adr
About:Sumitomo Pharma Co., Ltd. engages in manufacture, purchase, and sale of pharmaceutical products for medical treatment in Japan, North America, and Asia. The company offers therapeutic agents for parkinson's disease, type 2 diabetes, advanced prostate cancer, uterine fibroids and endometriosis, overactive bladder, and pediatric congenital athymia. It also provides atypical antipsychotic, generic products, antiepileptic, atypical antipsychotic, and carbapenem antibiotic. In addition, the company offers veterinary drugs, medical devices, etc. It has collaboration and license agreement with Otsuka Pharmaceutical Co., Ltd. The company was formerly known as Sumitomo Dainippon Pharma Co., Ltd. and changed its name to Sumitomo Pharma Co., Ltd. in April 2022. The company was incorporated in 1897 and is headquartered in Osaka, Japan. Sumitomo Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited.
Sector:Healthcare
Address:6-8, Doshomachi 2-chome, Osaka, Japan, 541-0045
Website:https://www.sumitomo-pharma.com
CIK:0001446601
ISIN:US8656141012
FIGI:BBG009QT6YR8
LEI:529900D60UKVYLJ2OJ79

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

FUNDAMENTALS

Trailing P/E:27.50 
Forward P/E:21.19 
Price to Sales:0.01 
Price to Book:3.67 
Revenue:416.159B 
EBITDA:61.013B 
Shares:397.29M 
Market Cap:4.821B 

TECHNICAL INDICATORS

MA5:12.936.6%
MA10:15.7729.9%
MA20:12.563.5%
STO9:1.08 
STO14:16.19 
RSI14:54.80
WPR14:-83.72 
MTM14:2.39
ROC14:0.24 
ATR:2.28 
Week High:14.4819.3%
Week Low:12.001.1%
Month High:24.48101.7%
Month Low:12.00